Cas:30093-99-3 4,4-dimethyl-5H-1,3-oxazole manufacturer & supplier

We serve Chemical Name:4,4-dimethyl-5H-1,3-oxazole CAS:30093-99-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,4-dimethyl-5H-1,3-oxazole

Chemical Name:4,4-dimethyl-5H-1,3-oxazole
CAS.NO:30093-99-3
Synonyms:EINECS 250-045-7;4,4-Dimethyl-2-oxazoline;4,4-dimethyl-2-isoxazoline;MFCD00014507;4,4-Dimethyloxazoline;4,4-dimethyl-4,5-dihydrooxazole;4,5-dihydro-4,4-dimethyloxazole
Molecular Formula:C5H9NO
Molecular Weight:99.13110
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:99-100ºC
Density:0.94
Index of Refraction:1.419-1.424
PSA:21.59000
Exact Mass:99.06840
LogP:0.25910

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993
Packing Group:II


Contact us for information like EINECS 250-045-7 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,5-dihydro-4,4-dimethyloxazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4-Dimethyl-2-oxazoline Use and application,4,5-dihydro-4,4-dimethyloxazole technical grade,usp/ep/jp grade.


Related News: In recent years, it has benefited significantly from the development of a broad range of enabling technologies, leading biocatalysis to become an established methodology for efficient, sustainable manufacturing, especially within the drug development industry. 2-(6-Hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-ca rboxylic acid manufacturers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-4-carbonitrile suppliers in addition to standard therapy. The trial did not meet its primary endpoint based on the SLE Responder Index 4 (SRI4) composite measure. tert-butyl N-[2-(5-bromo-1H-indol-3-yl)ethyl]carbamate vendor & factory.